Literature DB >> 22682779

"In vivo" imaging of atherosclerosis.

Augusto Gallino1, Matthias Stuber, Filippo Crea, Erling Falk, Roberto Corti, John Lekakis, Jürg Schwitter, Paolo Camici, Oliver Gaemperli, Marcello Di Valentino, John Prior, Hector M Garcia-Garcia, Charalambos Vlachopoulos, Francesco Cosentino, Stephan Windecker, Giovanni Pedrazzini, Richard Conti, François Mach, Raffaele De Caterina, Peter Libby.   

Abstract

Atherosclerosis is a systemic and multifocal disease, which starts early in life, and that usually takes decades before overt disease eventually appears as a consequence of progressive obstruction or abrupt thrombotic occlusion. This silent course makes necessary to develop predictors of disease long before symptomatic lesions develop. Besides several classical risk factors and new emerging humoral risk predictors, imaging may constitute a formidable diagnostic and prognostic tool in order to identify presence, extension, progression (or regression) of disease as well as vulnerability of atherosclerotic lesions. This review summarizes the rapidly growing clinical and research field in imaging atherosclerosis from different perspectives opening important opportunities for timely detection and treatment of atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22682779     DOI: 10.1016/j.atherosclerosis.2012.04.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  How does lipid lowering prevent coronary events? New insights from human imaging trials.

Authors:  Peter Libby
Journal:  Eur Heart J       Date:  2015-01-08       Impact factor: 29.983

2.  Chemokine receptors: Key for molecular imaging of inflammation in atherosclerosis.

Authors:  Yongjian Liu; Pamela K Woodard
Journal:  J Nucl Cardiol       Date:  2018-03-07       Impact factor: 5.952

3.  Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein.

Authors:  Anders Orbom; Bo Jansson; Alexandru Schiopu; Susan Evans-Axelsson; Jan Nilsson; Gunilla Nordin Fredrikson; Sven-Erik Strand
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

4.  Intracranial arterial calcifications as a prognostic factor for subsequent major adverse cardiovascular events (MACE).

Authors:  Frederik F Strobl; Beatrice Kuhlin; Robert Stahl; Bastian O Sabel; Andreas D Helck; Andreas Schindler; Matthias Witt; Fabian Bamberg; Maximilian F Reiser; Tobias Saam
Journal:  Radiol Med       Date:  2018-01-30       Impact factor: 3.469

Review 5.  Contrast-enhanced ultrasound: clinical applications in patients with atherosclerosis.

Authors:  Arend F L Schinkel; Mathias Kaspar; Daniel Staub
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-24       Impact factor: 2.357

6.  Association of Food and Alcohol Consumption with Peripheral Atherosclerotic Plaque Volume as Measured by 3D-Ultrasound.

Authors:  Maria Noflatscher; Michael Schreinlechner; Philip Sommer; Philipp Deutinger; Markus Theurl; Rudolf Kirchmair; Axel Bauer; Peter Marschang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

7.  Detection of Vascular Reactive Oxygen Species in Experimental Atherosclerosis by High-Resolution Near-Infrared Fluorescence Imaging Using VCAM-1-Targeted Liposomes Entrapping a Fluorogenic Redox-Sensitive Probe.

Authors:  Simona-Adriana Manea; Mihaela-Loredana Vlad; Daniela Rebleanu; Alexandra-Gela Lazar; Ioana Madalina Fenyo; Manuela Calin; Maya Simionescu; Adrian Manea
Journal:  Oxid Med Cell Longev       Date:  2021-03-09       Impact factor: 6.543

Review 8.  Ultrasound tissue characterization of vulnerable atherosclerotic plaque.

Authors:  Eugenio Picano; Marco Paterni
Journal:  Int J Mol Sci       Date:  2015-05-05       Impact factor: 5.923

9.  Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus.

Authors:  Michael A Bruckman; Kai Jiang; Emily J Simpson; Lauren N Randolph; Leonard G Luyt; Xin Yu; Nicole F Steinmetz
Journal:  Nano Lett       Date:  2014-02-17       Impact factor: 11.189

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.